Harvard Bioscience
HBIO
HBIO
82 hedge funds and large institutions have $65.1M invested in Harvard Bioscience in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 19 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
46% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 35
Holders
82
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.69M | |
| 2 | +$965K | |
| 3 | +$530K | |
| 4 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$419K |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$417K |
Top Sellers
| 1 | -$2.26M | |
| 2 | -$891K | |
| 3 | -$875K | |
| 4 |
KAM
Knightsbridge Asset Management
Newport Beach,
California
|
-$831K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$744K |